Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility

Acta Radiologica

Volumn 50, Issue 2, 2009, Pages 201-204

  Basu, S ^a,b   Li, G ^a   Bural, G ^a   Alavi, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Lymphoma; PET; PET CT; Thyroid

Indexed keywords

B-CELL LYMPHOMAS; CELL CHANGES; CLINICAL MANAGEMENTS; CLINICAL UTILITIES; COMPLETE RESPONSE; DIFFUSE LARGE-B-CELL LYMPHOMAS; FDG PETS; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; IMAGING MODALITIES; LYMPHOMA; NON-HODGKIN LYMPHOMAS; PAUCITY OF DATUM; PET; PET SCANS; PET-CT; SEMI-QUANTITATIVE; STANDARDIZED UPTAKE VALUES; THERAPEUTIC INTERVENTIONS; THYROID; THYROID GLANDS; TOMOGRAPHY IMAGING; WHOLE BODIES;

DIAGNOSTIC RADIOGRAPHY; MAGNETIC RESONANCE IMAGING; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LYMPHOMA; MALE; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61449260153     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850802620689     Document Type: Article

References (16)

1. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999;26:316-23.
2. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondazo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623-39.
3. Ruggiero FP, Frauenhoffer E, Stack BC. Thyroid lymphoma: a single institution's experience. Otolaryngol Head Neck Surg 2005;133:888-96.
4. Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid 1999;9:1273-80.
5. Ha CS, Shadle KM, Medeiros LJ, Wilder RB, Hess MA, Cabanillas F, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 2001;91:629-35.
6. Marchesi M, Biffoni M, Biancari F. False-positive finding on 18F-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: a case report. Jpn J Clin Oncol 2004;34:280-1.
7. Lin EC. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med 2007;32: 152-3.
8. Roldán-Valadez E, Ortega-López N, Cervera-Ceballos E, Valdivieso-Cárdenas G, Vega-González I, Granados-García M. Whole-body (18) F-FDG PET/CT in primary non-Hodgkin's lymphoma of the thyroid associated with Hashimoto's thyroiditis and bilateral kidney infiltration. Rev Esp Med Nucl 2008;27:34-9.
9. Chander S, Zingas AP, Bloom DA, Zak IT, Joyrich RN, Getzen TM. Positron emission tomography in primary thyroid lymphoma. Clin Nucl Med 2004;29:572-3.
10. Mikosch P, Würtz FG, Gallowitsch HJ, Kresnik E, Lind P. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid. Wien Med Wochenschr 2003;153:89-92.
11. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579-86.
12. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571-8.
13. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fiuorodeoxyglucose positron emission tomography. Thyroid 1998;8:765-72.
14. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PET. Exp Clin Endocrinol Diabetes 2000;108:191-6.
15. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48:896-901.
16. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007; 28:373-81.